The Inventing Press

OMEROS CORP

Financial highlights

MetricFY 12/31/25FY 12/31/24FY 12/31/23FY 12/31/22FY 12/31/21
Income Statement
Selling, general & administrative$41.5M$47.4M$49.7M$50.7M$54.8M
Research and development$81.3M$119.5M$114.9M$112.7M$118.8M
Operating income-$122.8M-$167.0M-$164.5M-$163.4M-$173.6M
Interest expense$960,000$24.7M$30.8M$22.7M$19.7M
Pretax income-$2.8M-$180.3M-$174.9M-$182.0M-$191.5M
Income tax expense$2.0M$2.3M$0$0$0
Net income-$3.4M-$156.8M-$117.8M$47.4M$194.2M
Balance Sheet
Cash and equivalents$9.7M$3.4M$7.1M$11.0M$100.8M
Current assets$215.7M$134.1M$217.9M$443.2M$248.0M
Total assets$325.6M$277.1M$378.3M$591.0M$419.3M
Current liabilities$78.1M$79.5M$53.3M$136.4M$51.8M
Total debt$68.4M$187.8M$215.9M$320.0M$320.0M
Stockholders' equity-$121.2M-$182.6M-$25.0M$85.7M$23.8M
Cash Flow Statement
Cash from operations-$116.1M-$148.8M$74.7M-$86.5M-$109.7M
Depreciation and amortization$964,000$950,000$920,000$952,000$1.4M
Stock-based compensation$8.2M$10.5M$11.7M$14.1M$17.6M
Capital expenditure$65,000$165,000$426,000$113,000$277,000
Free cash flow-$116.2M-$149.0M$74.3M-$86.6M-$110.0M
Share repurchases$0$11.9M$4.7M$0$0
Impairments$0$0$0$0$0

Shares outstanding 72.4M · Free float 80.8%

Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.

Coverage